tradingkey.logo
tradingkey.logo
Search

Fulgent Genetics Inc

FLGT
Add to Watchlist
21.550USD
+0.280+1.32%
Close 09-24 16:00(ET)
612.02MMarket Cap
LossP/E TTM

Fulgent Genetics Inc (FLGT) Stock Price Target & Forecast

Analyst Rating

Based on 1 analysts giving stock ratings to Fulgent Genetics Inc in the past month.

Hold
0 Strong Buy
0 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
19.000USD-10.67%

FLGT Analyst Recommendation Trends

In the current month, FLGT has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. FLGT average Analyst price target in the last month is 19.000.

2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
Strong Buy
0
0
0
0
0
0
0
0
Buy
0
0
0
0
1
2
2
2
Hold
1
1
1
1
1
1
1
1
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
1
1
1
1
2
3
3
3

FLGT Analyst Rating for Peer Comparison

Updated: Sep 24, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
CVS Health Corp
CVS
7
18
4
0
0
29
HCA Healthcare Inc
HCA
5
9
11
1
0
26
Teladoc Health Inc
TDOC
2
4
19
0
0
25
Natera Inc
NTRA
10
11
3
0
0
24
Tenet Healthcare Corp
THC
5
14
4
0
0
23
Universal Health Services Inc
UHS
2
4
15
1
0
22
Labcorp Holdings Inc
LH
7
9
4
0
0
20
Quest Diagnostics Inc
DGX
5
5
9
0
0
19
Privia Health Group Inc
PRVA
6
12
1
0
0
19
Brightspring Health Services Inc
BTSG
7
12
0
0
0
19

Financial Forecasting

Based on analysts' estimates, FLGT EPS is projected to reach -0.650 in FY2026Q3, following reported EPS of -1.054 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.03
-0.10
-0.46
-0.65
-0.69
Actual
-0.76
-0.80
-1.05
--
--
Surprise
-2619.37%
-665.64%
-129.23%
--
--

FAQs

What is Fulgent Genetics Inc's expected revenue for the next quarter?

Fulgent Genetics Inc's expected revenue is 86.30M.

What is Fulgent Genetics Inc's price target?

Analysts forecast that Fulgent Genetics Inc's price target is USD 19.00, with the highest forecast at USD 19.00 and the lowest forecast at USD 19.00.

How have Fulgent Genetics IncFLGT's recent earnings per share performed?

The market expectation was USD -1.05, while Fulgent Genetics IncFLGT's earnings per share (EPS) for the previous quarter was USD -0.80. EPS for the next quarter is expected at USD -0.65.

What is the analyst rating for Fulgent Genetics Inc?

Based on the ratings of Fulgent Genetics Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.